Cargando…

What happens next: Radiation oncology after COVID?

Detalles Bibliográficos
Autores principales: Chandra, Ravi A., Thomas, Charles R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261067/
https://www.ncbi.nlm.nih.gov/pubmed/32524037
http://dx.doi.org/10.1016/j.ctro.2020.05.009
_version_ 1783540437530705920
author Chandra, Ravi A.
Thomas, Charles R.
author_facet Chandra, Ravi A.
Thomas, Charles R.
author_sort Chandra, Ravi A.
collection PubMed
description
format Online
Article
Text
id pubmed-7261067
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72610672020-06-01 What happens next: Radiation oncology after COVID? Chandra, Ravi A. Thomas, Charles R. Clin Transl Radiat Oncol Article Elsevier 2020-05-30 /pmc/articles/PMC7261067/ /pubmed/32524037 http://dx.doi.org/10.1016/j.ctro.2020.05.009 Text en © 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chandra, Ravi A.
Thomas, Charles R.
What happens next: Radiation oncology after COVID?
title What happens next: Radiation oncology after COVID?
title_full What happens next: Radiation oncology after COVID?
title_fullStr What happens next: Radiation oncology after COVID?
title_full_unstemmed What happens next: Radiation oncology after COVID?
title_short What happens next: Radiation oncology after COVID?
title_sort what happens next: radiation oncology after covid?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261067/
https://www.ncbi.nlm.nih.gov/pubmed/32524037
http://dx.doi.org/10.1016/j.ctro.2020.05.009
work_keys_str_mv AT chandraravia whathappensnextradiationoncologyaftercovid
AT thomascharlesr whathappensnextradiationoncologyaftercovid